𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FLT3 inhibitors in the treatment of acute myeloid leukemia : The start of an era?

✍ Scribed by Naveen Pemmaraju; Hagop Kantarjian; Farhad Ravandi; Jorge Cortes

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
269 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Progress in the treatment of acute myelo
Progress in the treatment of acute myeloid leukemia
✍ Farhad Ravandi; Alan K. Burnett; Edward D. Agura; Hagop M. Kantarjian πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract Significant progress in understanding the mechanisms leading to the development of acute myeloid leukemia (AML) has led to the identification of numerous molecular abnormalities that may be responsible for leukemogenesis. Over the same period, large trials have established standard regi

Coduplication of the MLL and FLT3 genes
Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia
✍ Rahman Jamal; Takeshi Taketani; Tomohiko Taki; Fumio Bessho; Teruaki Hongo; Hiro πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Abstract Tandem duplication (TD) of the __MLL__ or __FLT3__ gene in acute myeloid leukemia (AML) has been reported. We examined whether TD of these two genes occurs simultaneously. We analyzed 13 AML and 2 myelodysplastic syndrome patients, including 6 adult patients with trisomy 11 and 9 pediat

Gemtuzumab ozogamicin in the treatment o
Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia
✍ Francis Giles; Elihu Estey; Susan O'Brien πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 484 KB πŸ‘ 1 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized anti‐CD33 antibody (hP67.6) linked to N‐acetyl‐γ calicheamicin 1,2‐dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration

Clinical relevance of internal tandem du
Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia
✍ Der-Cherng Liang; Lee-Yung Shih; Iou-Jih Hung; Chao-Ping Yang; Shu-Huey Chen; Ta πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Recently, an internal tandem duplication of the __FLT3__ gene (__FLT3__/ITD) was found in approximately 20% of adult acute myeloid leukemia (AML) cases and associated with a poor outcome. However, there are few studies on __FLT3__/ITD in childhood AML, and the clinical si

Combined effects of FLT3 and NF-ΞΊB selec
Combined effects of FLT3 and NF-ΞΊB selective inhibitors on acute myeloid leukemia in vivo
✍ Chunmei Wang; Jie Lu; Yumei Wang; Songting Bai; Yingchao Wang; Lu Wang; Guangyao πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 376 KB

## Abstract FMS‐like tyrosine kinase 3 (FLT3) is an independent poor prognostic marker of acute myeloid leukemia (AML), and strategies that specifically target FLT3 are therefore of substantial interest. However, previous studies with FLT3 inhibitors as single agents in patients with AML showed few